Pyrazole compounds that modulate HSP90 activity
    3.
    发明申请
    Pyrazole compounds that modulate HSP90 activity 有权
    调节HSP90活性的吡唑化合物

    公开(公告)号:US20070191445A1

    公开(公告)日:2007-08-16

    申请号:US11502346

    申请日:2006-08-10

    摘要: Compounds of formula (I), pharmaceutical compositions comprising compounds of formula (I) and methods of inhibiting Hsp90 in a cell, treating or preventing a proliferation disorder in a mammal and treating cancer in a mammal comprising administering a compound of formula (I) to a patient or a cell. Variable R5 is an optionally substituted heteroaryl; an optionally substituted 6 to 14-membered aryl; a bicyclic 9-member heterocycle optionally substituted at any substitutable nitrogen or carbon atoms; or a substituent R18, defined herein. Ring A is an aryl or a heteroaryl optionally further substituted with one or more substituents in addition to R3. Substituent R3 is defined herein.

    摘要翻译: 式(I)化合物,包含式(I)化合物的药物组合物和抑制细胞中Hsp90的方法,治疗或预防哺乳动物中的增殖病症并治疗哺乳动物的癌症,其包括给予式(I)化合物至 患者或细胞。 可变的R 5是任选取代的杂芳基; 任选取代的6至14元芳基; 任选在任何可取代的氮或碳原子上取代的双环9元杂环; 或本文定义的取代基R 18。 环A是芳基或杂芳基,除了R 3以外,还可被一个或多个取代基进一步取代。 取代基R 3在本文中定义。